SQI Diagnostics Granted Multiple U.S, EU and CDN Patents for Novel Multiplexing Technologies  
9/21/2012 9:41:00 AM

TORONTO--(BUSINESS WIRE)--SQI Diagnostics Inc. (TSX-V: SQD), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it has been granted multiple patents for its multiplexing platform and assay technologies. SQI has a total of 13 patents protecting multiple aspects of SQI Diagnostics’ multiplexing technologies.